Clinical Trials Directory

Trials / Unknown

UnknownNCT02824835

Strigolactones and Dysplastic Colonic Lesions or Cancer

The Effect of the Plant Hormones Strigolactones on Cultures of Dysplastic Colonic Lesions and Cancer

Status
Unknown
Phase
Study type
Observational
Enrollment
150 (estimated)
Sponsor
Meir Medical Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine the effects of the plant hormones strigolactones, on cell cultures of colonic polyps and colorectal cancer.

Detailed description

Strigolactones have been shown to anti-proliferative and pro-apoptotic effects in cell cultures of breast and prostate origin, partially by down-regulation of cyclin B1 and induction of cell cycle arrest. In this study the investigators intend to take biopsies from benign colonic polyps and cancer tissue, culture intestinal explants and generate immortalized primary cells as a platform to assess the effect of this plant hormone on cell viability, cell mobility, apoptosis and cytoskeleton modifications.

Conditions

Interventions

TypeNameDescription
PROCEDUREbiopsy during colonoscopysampling the lesion with forcept biopter

Timeline

Start date
2016-07-01
Primary completion
2017-12-01
Completion
2017-12-01
First posted
2016-07-07
Last updated
2016-07-07

Source: ClinicalTrials.gov record NCT02824835. Inclusion in this directory is not an endorsement.